Dendritic Cell Therapy Side Effects: What Patients Report and How They Are Managed
Quick answer: In published studies, dendritic cell (DC) vaccine therapy is generally reported to be well tolerated. The most common effects are mild and short-lived: redness, swelling or tenderness at the injection site, and flu-like symptoms such as fever, chills, tiredness, headache and aches. More serious reactions, including allergic reactions or immune effects on healthy tissue, are uncommon but possible. Your experience will depend on your cancer, your other treatments and your health, so report any new symptom to your treating team.
Medically reviewed by: [Reviewer name, qualification] | Last reviewed: [DD Month YYYY]
How dendritic cell therapy works, briefly
Dendritic cells are immune cells that show the immune system what to look for. In a typical autologous approach, a patient’s own blood cells are collected, dendritic cells are prepared and exposed to tumour-related material in the laboratory, and the cells are returned to the patient to help train the immune system. For a fuller explanation, see our dendritic cell therapy patient guide. Because the cells come from your own body and the approach is meant to prompt, not suppress, the immune system, the side effect pattern differs from chemotherapy. It is also different from checkpoint inhibitors; compare it with our overview of immunotherapy side effects.
What the research reports
Researchers have looked at safety in several ways, and the picture is consistent in broad terms.
- A large prospective safety survey. One study assessed 771 immune-cell therapy treatment profiles, 206 of which were DC vaccine therapy. It found grade 1 or 2 reactions at the injection site in about 10% of patients given DC vaccines, and concluded that immune-cell therapies, including DC vaccines, were well tolerated. Most serious (grade 3) events were linked to disease progression or chemotherapy rather than to the cell therapy.
- Trial consent forms. Information given to participants in registered clinical trials commonly lists fever, chills, fatigue, back and joint pain, nausea and headache as common effects, local redness, swelling, hardening or itching at the injection site, and occasional enlargement of nearby lymph nodes.
- Early-phase trials. Small phase 1 and 2 studies in several cancers have reported mostly mild effects such as fatigue, injection-site reactions, fever and chills, with a few allergic or hypersensitivity reactions in some trials.
Rates differ between studies because the vaccines, patients, cancers and accompanying treatments differ. These figures describe research settings and are not a promise of what you will experience.
Common, usually mild effects
At the injection site
Redness, mild swelling, warmth, itching or a firm, tender area under the skin can appear within hours to a day or two. These usually settle without treatment, but tell your team if the area becomes very painful, increasingly red, hot or starts to ooze, since infection or a stronger reaction needs assessment.
Flu-like symptoms
A low-grade fever, chills, fatigue, body or joint aches, headache and mild nausea can follow a dose. They are generally short-lived and are thought to reflect the immune system responding. Rest, fluids and any medicines your doctor has advised are usual measures. Do not take over-the-counter painkillers or fever tablets regularly without asking your team, because fever can be important information during cancer treatment.
Less common effects to be aware of
- Swollen lymph nodes near the injection area, usually temporary.
- Allergic reactions, such as rash, hives or breathing difficulty. Trial protocols list allergic rash, hives and rarely anaphylaxis as potential effects, so severe symptoms need urgent care.
- Immune effects on healthy tissue. Trial documents note the possibility of autoimmune reactions. Loss of skin pigment (vitiligo) has been seen in melanoma patients in some studies.
- Effects of collecting blood cells. Collection of your cells can cause fever, chills, or discomfort, and if a larger intravenous line is needed there are small risks such as bleeding. Your team will explain how this is handled.
Clinical trial consent forms also note that it is theoretically possible for a cancer vaccine not to help or, rarely, to affect tumour growth unfavourably. This is why monitoring and honest review of your scans and reports matter. Our guide to the signs that immunotherapy is working explains how response is usually checked.
When to call your treating team
Contact your team the same day, or go to an emergency department, if you have any of these:
- Difficulty breathing, swelling of the lips, face or throat, or widespread hives.
- A high fever, or any fever if you are also receiving chemotherapy, because low white blood cell counts make infection dangerous.
- Chest pain, a racing heartbeat, fainting or sudden leg swelling.
- An injection site that is spreading, very painful, hot or discharging.
- Symptoms that are new, severe or not settling, even if you are unsure they are related.
If you are also on chemotherapy, our article on cancer-related neutropenia explains why fever needs prompt attention.
Questions to ask before starting
- What reactions should I expect after each dose, and for how long?
- Which of my other conditions or medicines, especially steroids or immune-suppressing drugs, could affect this?
- Who do I call out of hours, and what symptoms need emergency care?
- How will we check whether the treatment is helping, and what will we do if it is not?
Our walkthrough of what to expect at your first Denvax consultation shows how these conversations usually go, and our guide to dendritic cell therapy cost in India covers what you pay for.
Care at Denvax
Denvax Cancer Center in Vasant Vihar, New Delhi, has treated over 25,000 patients since 2004 and offers chemotherapy, radiotherapy, targeted therapy and dendritic cell immunotherapy. We do not offer cancer testing, screening or diagnostics and are not a surgical centre, so please bring your existing reports. Your Denvax doctor will explain the specific schedule, expected reactions and monitoring plan that apply to you.
Frequently asked questions
Does dendritic cell therapy cause hair loss or severe nausea like chemotherapy?
Hair loss and heavy nausea are typical of many chemotherapy drugs, not of DC vaccines. Research reports mild nausea in some patients, but if you receive chemotherapy alongside, its own side effects will apply.
How long do side effects last after a dose?
Injection-site and flu-like symptoms are generally reported as short-lived, often settling within a day or two. Tell your team if they last longer or worsen.
Is dendritic cell therapy safe with chemotherapy or radiotherapy?
Some studies combine them, but timing and compatibility depend on your regimen. Your oncologist and the Denvax doctors should coordinate so treatments are sequenced appropriately.
Can dendritic cell therapy cause an autoimmune reaction?
It is a recognised possibility and is listed in trial documents, though it is not common. Report symptoms such as new rash, joint swelling or unusual tiredness.
Who should not have dendritic cell therapy?
Eligibility depends on your cancer, other treatments, blood counts and medical history, including any autoimmune disease or immune-suppressing medicines. A doctor must assess this individually; see our immunotherapy eligibility guide for general principles.
Results may vary. Consult your oncologist. This article summarises published research and is not medical advice. Dendritic cell therapy is not a cure and does not replace treatment advised by your oncologist.
Ask a Denvax doctor about safety and your treatment plan
Bring your reports and list of current medicines to Denvax Cancer Center, 18 Poorvi Marg, Vasant Vihar, New Delhi 110057.
अपनी रिपोर्ट और चल रही दवाओं की सूची के साथ Denvax Cancer Center में परामर्श के लिए संपर्क करें।
- इम्यूनोथेरेपी क्या है? कैंसर में कैसे काम करती है, प्रकार और खर्च
- Immunotherapy for Hodgkin Lymphoma in India: Nivolumab, Pembrolizumab and When They Are Used
